About half a dozen global funds, such as Blackstone, Carlyle, PAG, CVC Capital, BPEA EQT, Brookfield Asset Management and Apax Partners, have evinced interest in acquiring Hyderabad-based pharmaceutical company Sai Life...
Cipla to acquire South Africa-based Actor Pharma
Drug major Cipla on Monday said its unit has inked a pact to acquire South Africa-based Actor Pharma. Cipla South Africa, a wholly-owned subsidiary of the Mumbai-based drug major, has inked a binding term sheet with...
Permira to buy UK pharma services firm Ergomed for $886 mln
European private equity firm, Permira, has agreed to buy British biopharmaceutical services company Ergomed for about 703.1 million pounds ($886.40 million), the two firms said on Monday, in the latest UK healthcare...
Biocon acquires Eywa Pharma’s US-based plant for $7.7 million
Biotechnology major Biocon said its unit has acquired Eywa Pharma Inc’s oral solid dosage manufacturing facility in the US for $7.7 million (over Rs 63 crore). Biocon Generics Inc has acquired Eywa’s...
Amgen gets FTC’s go-ahead for $27.8 billion Horizon deal
The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to extend the market...
Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for funds
Torrent Pharma is cranking up its efforts to put together financing to buy out the promoter family of Cipla, said several people with knowledge of the matter, emerging as a key contender to conclude the largest pharma...
Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PE
In what would be its boldest move as yet, Torrent Pharma has joined the fray to buy out the Hamied family, the promoters of Cipla – a company that is more than double (2.3x) its FY23 consolidated revenues, and 2.3 times...
Lupin acquires two diabetes brands from Boehringer Ingelheim
Lupin said it has acquired diabetes brands Ondero (linagliptin) and Ondero Met (linagliptin and metformin) from Boehringer Ingelheim including the trademark rights associated with these brands for 26 million euros (Rs...
ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences
Private equity (PE) firm ChrysCapital remains firmly in the race to acquire Glenmark Pharma’s stake in Glenmark Life Sciences (GLS), with reports about detergent-to-chemicals maker Nirma closing on the deal doing...
Novo Nordisk to acquire obesity drug developer Inversago
Danish drug maker Novo Nordisk said it would acquire Canadian company Inversago Pharma in a $1.07 billion deal including the development of an appetite regulator. Inversago is a privately owned company which develops...
Blackstone sets its sights on buying out Hamieds from Cipla
Blackstone, the world’s largest private equity fund, is set to submit a non-binding bid as early as next week to acquire the entire 33.47% promoter stake in Cipla, India’s third-largest generics company by revenues...
Strides sells arm’s manufacturing unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday said it has entered into a binding agreement to sell biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma (SBL) to Syngene International on a slump sale...
